Radiation Necrosis in Pediatric Proton Therapy for Central Nervous System Tumors: Current Evidence and Future

Taha Kassim Dohadwala1, Soumiya Nadar2, Arusha Ayub3

  • 1Department of Medicine, David Tvildiani Medical University, Tbilisi, Georgia.

Insights

Radiation necrosis (RN) is a serious complication of pediatric proton beam therapy (PBT). Understanding its risk factors, imaging, and management is vital for balancing tumor control and neurocognitive function.

Area of Science:

  • Pediatric Oncology
  • Radiation Oncology
  • Neurology

Background:

  • Radiation necrosis (RN) is a significant late complication following central nervous system irradiation in children.
  • Proton beam therapy (PBT) is increasingly used to minimize normal-tissue exposure, necessitating a deeper understanding of RN.
  • Factors influencing RN incidence in pediatric PBT include tumor characteristics, dose-volume parameters, follow-up duration, and linear energy transfer (LET).

Purpose of the Study:

  • To review and synthesize current knowledge on risk factors, imaging evaluation, and management of radiation necrosis in pediatric patients treated with proton beam therapy.
  • To highlight the unique considerations of PBT, such as elevated LET, in the context of RN.
  • To emphasize the need for improved risk prediction and management strategies.

Main Methods:

  • Review of existing literature on radiation necrosis following pediatric proton beam therapy.
  • Analysis of reported incidence rates and associated risk factors.
  • Evaluation of advanced magnetic resonance imaging (MRI) techniques for differentiating RN from tumor progression.
  • Summary of current management strategies.

Main Results:

  • RN incidence following pediatric PBT varies and is influenced by tumor specifics, dose-volume metrics, follow-up length, younger age, chemotherapy, and peritumoral white-matter dose.
  • Elevated LET may present a unique risk profile compared to photon therapy.
  • Advanced MRI techniques aid in distinguishing RN from progression, though accuracy is not perfect.
  • Management options include corticosteroids, bevacizumab, hyperbaric oxygen, and surgery.

Conclusions:

  • Understanding RN in pediatric PBT is crucial for optimizing treatment outcomes and preserving neurocognitive function.
  • Prioritizing LET-aware planning, vigilant imaging surveillance, and prospective studies with radiogenomic profiling is essential for improved risk prediction and management.
  • Further research is needed to refine strategies for managing RN and enhancing long-term quality-of-life in pediatric patients.